Literature DB >> 27766386

[Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].

A Schilimow1, B Wiechens2.   

Abstract

In this article, a case of recurrent epithelial defects in neurotrophic keratopathy is described. Multiple abrasions of the corneal epithelium with a therapeutic contact lens, corneal stitches, and amniotic membrane transplantation in combination with artificial tears brought only short-term success. However, a botulinum toxin A induced protective ptosis could finally achieve permanent epithelial closure. As this case shows, protective ptosis can be a promising approach in spite of multiple previous ineffective therapeutic efforts.

Entities:  

Keywords:  Amniotic membrane transpantation; Botulinum toxin A; Corneal epithelial defects; Neurotrophic keratopathy; Protective ptosis

Mesh:

Substances:

Year:  2017        PMID: 27766386     DOI: 10.1007/s00347-016-0377-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  10 in total

Review 1.  Neurotrophic keratitis.

Authors:  S Bonini; P Rama; D Olzi; A Lambiase
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

Review 2.  Corneal nerves: structure, contents and function.

Authors:  Linda J Müller; Carl F Marfurt; Friedrich Kruse; Timo M T Tervo
Journal:  Exp Eye Res       Date:  2003-05       Impact factor: 3.467

3.  [Botulinum toxin injection for production of ptosis].

Authors:  R-L Merté; I M Lanzl
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

4.  Scleral contact lens management of bilateral exposure and neurotrophic keratopathy.

Authors:  Fiona Grey; Fiona Carley; Susmito Biswas; Cindy Tromans
Journal:  Cont Lens Anterior Eye       Date:  2012-08-15       Impact factor: 3.077

Review 5.  Management of neurotrophic keratopathy.

Authors:  A Lambiase; P Rama; L Aloe; S Bonini
Journal:  Curr Opin Ophthalmol       Date:  1999-08       Impact factor: 3.761

6.  Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial.

Authors:  Sudarshan Khokhar; Tanie Natung; Parul Sony; Namrata Sharma; Nutan Agarwal; Rasik B Vajpayee
Journal:  Cornea       Date:  2005-08       Impact factor: 2.651

7.  Botulinum toxin A induced protective ptosis.

Authors:  G G Adams; C M Kirkness; J P Lee
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

8.  [Conservative and surgical treatment of neurotrophic keratopathy].

Authors:  B Seitz; M Grüterich; C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

9.  Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.

Authors:  Abdelouahab Aifa; Julie Gueudry; Alexandre Portmann; Agnès Delcampe; Marc Muraine
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

10.  Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects.

Authors:  Bennie H Jeng; William J Dupps
Journal:  Cornea       Date:  2009-12       Impact factor: 2.651

  10 in total
  3 in total

Review 1.  [Modern non-cosmetic treatment with botulinum toxins].

Authors:  A Straube
Journal:  Internist (Berl)       Date:  2017-12       Impact factor: 0.743

Review 2.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

Review 3.  Diabetic Corneal Neuropathy.

Authors:  Hassan Mansoor; Hong Chang Tan; Molly Tzu-Yu Lin; Jodhbir S Mehta; Yu-Chi Liu
Journal:  J Clin Med       Date:  2020-12-06       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.